Eagle Pharmaceuticals Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street futures fall as oil, Treasury yields rise on Iran tensions
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- Berkshire’s Abel says data centers are energy opportunity
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
March 17, 2015 9:04 AM EDTEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced the pricing of an underwritten public offering of 1,320,276 shares of its common stock at a price to the public of $42.00 per share. 1,190,476 shares are being sold by Eagle and 129,800 shares are being sold by certain stockholders of the... More
